← All projects
Organ repair and replacement

LyGenesis ectopic liver regeneration

LyGenesis

This could keep someone alive and healthier when an organ is failing by repairing it, supporting it or replacing it.

WHAT IT IS TRYING TO CHANGE

What the project is doing

LyGenesis ectopic liver regeneration is being developed as part of the wider effort to prevent, delay or repair age-related decline.

What this could do for you

This could keep someone alive and healthier when an organ is failing by repairing it, supporting it or replacing it.

What has to happen next

The next major checkpoint is whether the human benefit is large and consistent enough to justify a larger study.

What could stop it

Promising signals can disappear in a larger study, and the best dose, long-term safety and real benefit may still be uncertain.

WHERE IT STANDS

Current evidence and outlook

LyGenesis ectopic liver regeneration is being developed as part of the wider effort to prevent, delay or repair age-related decline.

Likely path

Roughly 3–7 years to broader access if results remain positive.

Why this estimate

A larger confirmatory study and regulatory review would normally still be needed.

Record checked: 2026-08-27

ORIGINAL EVIDENCE

Research details and sources

The sources below support the project record. RejuvAccess separately checks whether a practical route is open and worth pursuing.

  1. LyGenesis — safety board approves continuation and dose increase
  2. ClinicalTrials.gov — LYG-LIV-001 Phase 2a study
MAKE IT PERSONAL

Could this matter for your situation?

Ask RejuvAccess to check the evidence, access route, cost and next step for you.

Start an access check